Publication Details

Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: A report from the Children's Oncology Group.

Leavey PJ, Mascarenhas L, Marina N, Chen Z, Krailo M, Miser J, Brown K, Tarbell N, Bernstein ML, Granowetter L, Gebhardt M, Grier HE. Pediatr Blood Cancer. 2008; 51 (3): 334-8

The prognosis for patients with recurrent Ewing sarcoma (EWS) is very poor with 5-year survival of 13%.

PubMedID: 18506764